Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01537
|
|||||
| Drug Name |
Coelenterazine
|
|||||
| Synonyms |
coelenterazine; Coelenteramine; Oplophorus luciferin; UNII-3O1CB88RRD; CLZN; 8-benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one; coelenterate luciferin; Coelenterazine, native; 3O1CB88RRD; MFCD00467176; C-7001; C-7002; 8-benzyl-6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-7H-imidazo[1,2-a]pyrazin-3-one; 8-Benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo-[1,2a]pyrazin-3(7H)-one; 2-(p-Hydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo[1,2-a]pyrazin-3-(7H)-one
|
|||||
| Indication | Inflammatory bowel disease [ICD11: DD7Z] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C26H21N3O3
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)CC2=NC(=CN3C2=NC(=C3O)CC4=CC=C(C=C4)O)C5=CC=C(C=C5)O
|
|||||
| InChI |
InChI=1S/C26H21N3O3/c30-20-10-6-18(7-11-20)15-23-26(32)29-16-24(19-8-12-21(31)13-9-19)27-22(25(29)28-23)14-17-4-2-1-3-5-17/h1-13,16,30-32H,14-15H2
|
|||||
| InChIKey |
LNCOEGVEEQDKGX-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 55779-48-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 423.5 | Topological Polar Surface Area | 90.9 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
5.5
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:2311
|
|||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | National Center for Advancing Translational Science-Inxight: drug (3O1CB88RRD) | |||||
| 2 | Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1702-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.